Form 4 for DXCM Dexcom
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-15 · accession 0001093557-25-000245 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-08-18 | 2025-08-15 | DXCM | FOLETTA MARK G | Dir | S - Sale | $81.06 | -2,750 | 51.3K | -5% | -$222.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | S | D | 195 | $81.54 | 51,121 | I by Trust | — | — | (F3) Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the reporting person is a trustee. |
| 2 | Common | Common Stock | 2025-08-15 | S | D | 2,555 | $81.02 | 51,316 | I by Trust | — | — | (F1) On March 13, 2025, The Foletta Family Trust DTD 1/30/2015 (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan. (F2) This transaction was executed in multiple trades at prices ranging from $80.29 to $81.22. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |